Nobel Laureates Seek to Revoke Own CRISPR Patents Amid European Legal Scrutiny

In a significant development within the field of biotechnology, the scientists who were awarded the Nobel Prize for the invention of the gene-editing tool CRISPR have formally requested the revocation of two pivotal patents in Europe. This move follows indications from European officials that the patents might face annulment due to technical issues. For detailed information on this unfolding story, visit Law360.